Direct gastric invasion is associated with poor prognosis in esophageal squamous cell carcinoma involving the lower-third esophagus
World Journal of Gastrointestinal Oncology · 2026-11-15 · 18 (11)
DOI: 10.4251/wjgo.122992 ↗Abstract
BACKGROUND Direct gastric invasion in esophageal squamous cell carcinoma (ESCC) is uncommon, and its clinical significance remains poorly characterized. AIM To investigate the clinicopathological characteristics and prognostic impact of direct gastric invasion in ESCC. METHODS A retrospective analysis was conducted using a prospectively established single-center ESCC cohort including 398 patients enrolled between 2011 and 2020. Direct gastric invasion was defined as continuous tumor extension across the gastroesophageal junction on endoscopy. Treatment allocation was determined by a multidisciplinary team based on disease stage and patient condition. Survival outcomes were assessed using Kaplan-Meier analysis and Cox proportional hazards regression models. RESULTS Among the 398 patients with ESCC, 23 (5.8%) had direct gastric invasion, which was associated with advanced-stage disease, a high rate of lymph node metastasis (95%), and poor survival. The median overall survival was 10.6 months. Patients who underwent chemoradiotherapy (CRT) followed by surgery had the longest survival (12.6 months), compared with CRT alone (8.6 months) or best supportive care (1.7 months). In patients with lower-third ESCC, gastric invasion was associated with significantly worse survival. Multivariable Cox regression analysis identified gastric invasion as an independent predictor of poor survival (hazard ratio = 2.2, P = 0.01). CONCLUSION Direct gastric invasion in ESCC is associated with poor prognosis. Although CRT followed by surgery was associated with improved survival in this cohort, the observed differences across treatment modalities should be interpreted cautiously owing to potential selection bias.
EUVIMED